Helius Price To Sales Ratio from 2010 to 2024
| HSDT Stock | USD 0.45 0.02 4.65% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 7.58918571 | Current Value 7.21 | Quarterly Volatility 214.25172452 |
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
Helius | Price To Sales Ratio |
Latest Helius Medical's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Helius Medical Technologies over the last few years. Price to Sales Ratio is figured by comparing Helius Medical Techn stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Helius Medical sales, a figure that is much harder to manipulate than other Helius Medical Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Helius Medical's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 2.84 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Helius Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 267.68 | |
| Geometric Mean | 103.43 | |
| Coefficient Of Variation | 80.04 | |
| Mean Deviation | 202.74 | |
| Median | 436.63 | |
| Standard Deviation | 214.25 | |
| Sample Variance | 45,904 | |
| Range | 431 | |
| R-Value | (0.85) | |
| Mean Square Error | 13,335 | |
| R-Squared | 0.73 | |
| Significance | 0.00005 | |
| Slope | (40.94) | |
| Total Sum of Squares | 642,653 |
Helius Price To Sales Ratio History
About Helius Medical Financial Statements
Helius Medical shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 7.59 | 7.21 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.